Dare Bioscience, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-11.5M | $-672.7K | $-39.6M | $-23.3M | $-17.1M | $-22.1M |
| Depreciation & Amortization | — | $261.0K | $192.0K | $126.0K | $197.0K | $346.0K |
| Depreciation | $0 | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $15.8K | $9.0K | $2.4M | $885.0K | $622.0K | $529.0K |
| Net Cash from Operating Activities | $-2.5M | $-372.3K | $-31.9M | $-19.1M | $-16.6M | $-21.0M |
| Investing Activities | ||||||
| Capital Expenditures | $0 | $535.0K | $277.0K | $225.0K | $7.0K | $180.0K |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $9.9M | — | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $155.0K | — | — | — | — | — |
| Net Change in Cash | $7.5M | $-174.8K | $24.7M | $45.7M | $-11.2M | $1.4M |
| Free Cash Flow | $-2.5M | $-907.3K | $-32.2M | $-19.3M | $-16.6M | $-21.2M |